Annual Drug Patent Expirations for PHOSLO+GELCAPS
Phoslo Gelcaps is a drug marketed by Fresenius Medcl and is included in one NDA. It is available from three suppliers. There are two patents protecting this drug.
Drug patent litigation for PHOSLO GELCAPS.
The generic ingredient in PHOSLO GELCAPS is calcium acetate. Three suppliers are listed for this compound. Additional details are available on the calcium acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
